My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
AgendaItemPacket_SHsignature
>
Meetings
>
2024
>
08. August
>
2024-08-06 10:00 AM - Commissioners' Agenda
>
AgendaItemPacket_SHsignature
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
8/1/2024 1:14:10 PM
Creation date
8/1/2024 1:07:57 PM
Metadata
Fields
Template:
Meeting
Date
8/6/2024
Meeting title
Commissioners' Agenda
Location
Commissioners' Auditorium
Address
205 West 5th Room 109 - Ellensburg
Meeting type
Regular
Meeting document type
Supporting documentation
Supplemental fields
Item
Request to Approve a Resolution Accepting the Kroger Co. Multi-State Settlement Agreement
Order
2
Placement
Consent Agenda
Row ID
120774
Type
Resolution
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
58
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
made opioids epidemic -related expenditures in the past. This is the same <br />methodology used in the National Settlement Agreements for county and <br />intra-county allocations. A Participating County, and the Cities and Towns <br />within it may enter into a separate intra-county allocation agreement to <br />modify how the Opioid Funds are allocated amongst themselves, provided <br />the modification is in writing and agreed to by all Participating Local <br />Governments in the County. Such an agreement shall not modify any of <br />the other terms or requirements of this MOU. <br />b. 10% of the Opioid Funds received by the Region will be reserved, <br />on an annual basis, for administrative costs related to the OAC. The OAC <br />will provide an annual accounting for actual costs and any reserved funds <br />that exceed actual costs will be reallocated to Participating Local <br />Governments within the Region. <br />C. Cities and towns with a population of less than 10,000 shall be <br />excluded from the allocation, with the exception of cities and towns that <br />are Litigating Participating Local Governments. The portion of the Opioid <br />Funds that would have been allocated to a city or town with a population <br />of less than 10,000 that is not a Litigating Participating Local Government <br />shall be redistributed to Participating Counties in the manner directed <br />in C.4.a above. <br />d. Each Participating County, City, or Town may elect to have its <br />share re -allocated to the OAC in which it is located. The OAC will then <br />utilize this share for the benefit of Participating Local Governments within <br />that Allocation Region, consistent with the Approved Purposes set forth in <br />Exhibit A. A Participating Local Government's election to forego its <br />allocation of Opioid Funds shall apply to all future allocations unless the <br />Participating Local Government notifies its respective OAC otherwise. If a <br />Participating Local Government elects to forego its allocation of the <br />Opioid Funds, the Participating Local Government shall be excused from <br />the reporting requirements set forth in this Agreement. <br />e. Participating Local Governments that receive a direct <br />payment maintain full discretion over the use and distribution of their <br />allocation of Opioid Funds, provided the Opioid Funds are used solely for <br />Approved Purposes. Reasonable administrative costs for a Participating <br />Local Government to administer its allocation of Opioid Funds shall not <br />exceed actual costs or 10% of the Participating Local Government's <br />allocation of Opioid Funds, whichever is less. <br />f. A Local Government that chooses not to become a Participating <br />Local Government will not receive a direct allocation of Opioid Funds. <br />The portion of the Opioid Funds that would have been allocated to a Local <br />Government that is not a Participating Local Government shall be <br />
The URL can be used to link to this page
Your browser does not support the video tag.